California Cancer Reporting System Standards, Volume III
Eureka Hospital Transmit
Eureka Tumor Level
Eureka Admission Level
Behavior Code ICD-0-3 [NAACCR #523]
CS Site Specific Factor 22 [NAACCR #2876]
CS Site Specific Factor 23 [NAACCR #2877]
CS Site Specific Factor 25 [NAACCR #2879]
Histologic Type ICD-0-3 [NAACCR #522]
Primary Site [NAACCR #400]
If CS Site Specific Factor 22 [value] =998, CS Site Specific Factor 23 [value] must = 998.
If CS Site Specific Factor 23 [value],=998, CS Site Specific Factor 22 [value] must = 998.
This edit verifies that for cases using the Breast schema, SSF 22 (Multigene Signature Method) and SSF 23 (Multigene Signature Results) are coded consistently. That is, if one specifies "test not done", the other must also specify "test not done".
This edit first determines the correct CS schema by doing a function call to the CS Dynamic Link Library (dll). The function call passes Primary Site, Histologic Type ICD-O-3, and CS Site-Specific Factor25 (schema discriminator) to the dll and the CS schema name is returned.
This edit is skipped if any of the following conditions are true:
CS Site-Specific Factor22 is blank or 988
CS Site-Specific Factor23 is blank or 988
Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)
CS schema is invalid
If CS schema is Breast:
If CS Site-Specific Factor 22 = 998 (test not done), then CS Site-Specific Factor 23 must = 998 (test not done).
If CS Site-Specific Factor 23 = 998 (test not done), then CS Site-Specific Factor 22 must = 998 (test not done).
In the SEER*Edits software, the title of this edit is: IF374
7/27/11 | This new edit was created to comply with NAACCR 12.1.A. |
04/2014 |
Function call to the CS Dynamic Link Library updated to call "CStage0205.dll" instead of "CStage.dll." |